Ivermectin/Pyrantel Pamoate Chewable 136Mcg/326Mg
2,707 adverse event reports submitted to the FDA
Active Ingredients
Administration Routes
Species Affected
Most Affected Breeds
Most Reported Reactions
Outcome Breakdown
Data Summary
| Metric | Value |
|---|---|
| Total adverse event reports | 2,707 |
| Reports involving death | 29 |
| Case-fatality rate (reported events) | 110.0% |
| Distinct species in reports | 3 |
| Distinct breeds in reports | 20 |
| Distinct reactions reported | 20 |
| Active ingredients on file | 1 |
Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.
Ivermectin/Pyrantel Pamoate Chewable 136Mcg/326Mg Adverse Event Insights
The FDA Center for Veterinary Medicine database currently holds 2,707 adverse event reports referencing Ivermectin/Pyrantel Pamoate Chewable 136Mcg/326Mg, including 29 reports in which the animal died — a 110.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin/Pyrantel Pamoate Chewable 136Mcg/326Mg. Reported administration routes include Oral, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.
The species most frequently named in Ivermectin/Pyrantel Pamoate Chewable 136Mcg/326Mg reports are Dog (2,593 reports), Unknown (111 reports), Cat (3 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (463), Beagle (260), Retriever - Labrador (183) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.
The most commonly reported clinical signs associated with Ivermectin/Pyrantel Pamoate Chewable 136Mcg/326Mg are Digestive tract disorder NOS (1,416), Lack of efficacy (endoparasite) - hookworm (727), INEFFECTIVE, HEARTWORM LARVAE (632), Cardiac disorder NOS (619). Of the 2,604 reports with a coded outcome, Outcome Unknown is the leading category at 62.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin/Pyrantel Pamoate Chewable 136Mcg/326Mg.
Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates
Read our methodology — how this data is sourced, computed, and verified.